Haemophilia A

EMA ( European Medicines Agency ) has granted conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer,...


Novo Nordisk has announced the submission of a Biologics License Applications ( BLA ) to the US Food and Drug...


The European Commission ( EC ) has approved Alprolix ( rFIXFc ) for the treatment of haemophilia B in all...


Positive top-line results of the Kids B-LONG phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix...


Positive results of the Kids A-LONG phase 3 clinical study that evaluated the safety and efficacy of Eloctate, an investigational...


Researchers have previously reported the preliminary safety and efficacy data of a novel gene transfer approach in six subjects with...


The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee ( PRAC ) has reviewed the medicines Kogenate Bayer and Helixate NexGen...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of...


Cangene Europe has notified the Committee for Medicinal Products for Human Use ( CHMP ) that it wishes to withdraw...


Central nervous system ( CNS ) bleeding is one of the most severe and debilitating manifestations occurring in patients with...